Latest filing published 25 Aug 2026 for Nu-Med Plus, Inc..
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Filings by Fred Tejada span 2 companies, the busiest being Rise Gold Corp. and Nu-Med Plus, Inc. In total, 6 filings cover trades dated from 28 October 2015 to 8 July 2026.
Purchases make up the whole of the open-market record (3 purchases, €32k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant.
Half of the purchases are above €5,718 and half below. On 1 out of 3 purchases, another insider of the same company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Ninety days after publication, 3 purchases show a median change of -29.6%, with the price up in 0% of them. These figures describe past trades and do not predict future prices.
Most recently, on 25 August 2026, the filings show a transaction in Nu-Med Plus, Inc. The last purchase on record was published on 26 January 2017, which is 3,558 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations